# Lars Bullinger

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lars-bullinger/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,801 |
| Field | Acute Myeloid Leukemia Research |
| h-index | 96 |
| i10-index | 325 |
| Last Known Institution | German Cancer Research Center |
| OpenAlex ID | https://openalex.org/A5040956966 |
| ORCID iD | https://orcid.org/0000-0002-5890-5510 |
| Works | 960 |

## Researcher papers

- [MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L](https://scholariq.org/papers/mll-rearranged-leukemia-is-dependent-on-aberrant-h3k79-methylation-by-dot1l/)
- [Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/lomustine-temozolomide-combination-therapy-versus-standard-temozolomide-therapy/)
- [Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial](https://scholariq.org/papers/gene-mutations-and-treatment-outcome-in-chronic-lymphocytic-leukemia-results/)
- [Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia](https://scholariq.org/papers/musashi-2-regulates-normal-hematopoiesis-and-promotes-aggressive-myeloid/)
- [AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias](https://scholariq.org/papers/akt-foxo-signaling-enforces-reversible-differentiation-blockade-in-myeloid/)

## Researcher topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

## Researcher university

- [German Cancer Research Center](https://scholariq.org/institutions/german-cancer-research-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.